by Ashley J. Wennersherron, Pennsylvania State University Penn State researchers developed particles that target blood clots and visualize their structures well compared to traditional ultrasound imaging. These images show blood flowing from left to right: The top image does not have the particles, while the bottom one does. Credit: Penn State/Scott Medina Penn State College of Engineering researchers set out...
AMERICAN SOCIETY OF HEMATOLOGY New research suggests that it may be possible to simplify the diagnosis of deep vein thrombosis (DVT) without compromising accuracy. Contrary to the standard practice of administering several tests to diagnose DVT, using only a D-dimer blood test may help health care providers identify patients who require additional screening, according to a new...
by Ecole Polytechnique Federale de Lausanne gulation factor XII (FXII), and the mice without the enzyme had a highly reduced risk of thrombosis without bleeding side-effects. The discovery triggered a race for FXII inhibitors. The Laboratory of Therapeutic Proteins and Peptides of Professor Christian Heinis at EPFL has now developed the first synthetic inhibitor of...
by Mag. Johannes Angerer, Medical University of Vienna COVID-19, the disease caused by SARS-CoV-2, not only may lead to severe pneumonia but also to thrombosis in the lungs and, subsequently, to multi organ failure involving kidneys, liver and pancreas. These are the findings of a first major series of autopsies in Austria, conducted as part...
Study supports use of this simple, low-cost intervention even for patients without symptoms AMERICAN SOCIETY OF HEMATOLOGY (WASHINGTON, September 20, 2018) — People with deep-vein thrombosis (DVT) can substantially cut their risk of potentially debilitating complications by starting adequate compression therapy in the first twenty-four hours of DVT therapy (known as the acute phase of...
